Back
Sarepta Therapeutics Stock Price Chart
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).
Sell
38
SRPT
Sarepta Therapeutics
Last Price:
116.52
Seasonality Move:
12.59%
7 Day Trial
ALL ACCESS PASS
$
7
NOW is the time to get in on this trillion-dollar megatrend
Get it here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.31 | Sell |
| 20-day SMA: | 124.97 | Sell |
| 50-day SMA: | 126.53 | Sell |
| 200-day SMA: | 111.26 | Buy |
| 8-day EMA: | 120.3 | Sell |
| 20-day EMA: | 123.19 | Sell |
| 50-day EMA: | 122.85 | Sell |
| 200-day EMA: | 115.66 | Buy |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.99 | Sell |
| Relative Strength Index (14 RSI): | 30.42 | Sell |
| Chaikin Money Flow: | -241995 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (121.11 - 128.51) | Sell |
| Bollinger Bands (100): | (97.89 - 130.93) | Buy |
Sarepta Therapeutics Technical Analysis
| Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 116.51 while SRPT 8-day simple moving average is 121.31, which is a Sell signal.
- The stock price of SRPT is 116.51 while Sarepta Therapeutics 20-day SMA is 124.97, which makes it a Sell.
- Sarepta Therapeutics 50-day simple moving average is 126.53 while SRPT share price is 116.51, making it a Sell technically.
- SRPT stock price is 116.51 and Sarepta Therapeutics 200-day simple moving average is 111.26, creating a Buy signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
38
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a Sell
The current Sarepta Therapeutics [SRPT] share price is $116.51. The Score for SRPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
10.94B
Price in USD:
116.51
Share Volume:
450.66K
Sarepta Therapeutics 52-Week Range
52-Week High:
159.89
52-Week Low:
55.25
Sell
38
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?
The Sarepta Therapeutics stock price is 116.51 USD today. -
Will SRPT stock go up or go down?
Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sarepta Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 116.51 while SRPT 8-day exponential moving average is 120.30, which is a Sell signal.
- The stock price of SRPT is 116.51 while Sarepta Therapeutics 20-day EMA is 123.19, which makes it a Sell.
- Sarepta Therapeutics 50-day exponential moving average is 122.85 while SRPT share price is 116.51, making it a Sell technically.
- SRPT stock price is 116.51 and Sarepta Therapeutics 200-day simple moving average is 115.66, creating a Buy signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.72 per share, an increase next quarter of $3.22 per share, an increase this year of $5.19 per share, and an increase next year of $7.23 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
- SRPT Moving Average Covergence Divergence (MACD) indicator is -1.99, suggesting Sarepta Therapeutics is a Sell
- Sarepta Therapeutics Relative Strength Index (RSI) is 30.42, which suggest Sarepta Therapeutics is oversold
- The Bollinger Bands (25) for Sarepta Therapeutics is (121.11 - 128.51), which suggest Sarepta Therapeutics is a Buy
- The Bollinger Bands (100) for Sarepta Therapeutics is (97.89 - 130.93), which suggest Sarepta Therapeutics is a Buy
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.